Health
CanSinoBIO files application in China for COVID-19 vaccine approval – Devdiscourse
“The efficacy of Ad5-nCoV has met the relevant technical standards laid out by the World Health Organization and relevant standards and requirements set out …by…
CanSino Biologics Inc (CanSinoBIO) said on Wednesday it has filed an application in China for approval of its COVID-19 vaccine to become the country’s third locally developed shot allowed for use by the general public.
While China has yet to approve rival vaccines developed by Western drug makers, it has granted authorization to domestic products that have also gained ground in many developing countries battling a surge in coronavirus infections. CanSinoBIO said interim analysis of data from its…
-
Noosa News9 hours agoExperts share tiny home warning as interest from young people soars
-
Noosa News15 hours agoKarenia cristata species source of toxins in SA’s algal bloom, scientists believe
-
General23 hours agoASIC shone a light on private lending and did not like what it saw
-
General22 hours agoSir David Beckham receives knighthood from King Charles at Windsor, with wife to be known as Lady Victoria